Marie Duranteau

Marie Duranteau is an Associate and Program Manager at Sofinnova Partners, a European venture capital firm specializing in life sciences.12 Her current role is with the Sofinnova BioVelocita Strategy, which aims to accelerate biopharma academic projects in France, Italy, and the UK.1

Professional Background

Marie joined Sofinnova Partners in 2017 and has progressed through several roles within the company:

1. Intern (Oct 2017 - Mar 2018)
2. Junior Analyst (Apr 2018 - Jan 2020)
3. Analyst (Feb 2020 - Feb 2024)
4. Senior Analyst (Apr 2022 - Feb 2024)
5. Associate, BioVelocita Strategy (Dec 2023 - Present)1

In her current position, Marie works on fostering oncology projects and start-ups, collaborating with institutions like Gustave Roussy in France. Her team takes an operational role in bridging the gap between laboratory work and drug development.1

Education

Marie has a strong academic background in biology and entrepreneurship:

• PhD in Cellular Biology from Université Denis Diderot (Paris VII), focusing on the role of the kinase BubR1 in mitosis control and aneuploidy prevention1
• Master of Science in Entrepreneurship (Biotechnology) from HEC Paris1
• Master's degrees in Integrative Biology and Physiology from Université Pierre et Marie Curie and in Cellular and Developmental Biology from Université Paris Descartes1

Research Experience

Before joining Sofinnova Partners, Marie gained valuable research experience:

• Post-doctoral Researcher at Institut Jacques Monod/CNRS & University Paris Diderot (Dec 2015 - Aug 2016)
• PhD research at Institut Jacques Monod/CNRS & University Paris Diderot (Oct 2012 - Nov 2015)
• Research Intern at Institut Cochin (Oct 2011 - Jun 2012)1

Marie's expertise in cellular biology, combined with her business education and venture capital experience, positions her well for her role in accelerating biopharma projects and bridging the gap between academic research and commercial drug development.12